| TNFSF10 antibodies | |
| This is a review about TRAIL antibodies, based on 4 published articles using TRAIL antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited TRAIL antibody. Information in this review (with links to publications) can be searched freely. |
R & D SYSTEMS search R & D Systems TNFSF10 products
includes other brands or spellings
|
| ih | | R&D Systems mouse monoclonal antihuman TRAIL antibody (clone 75411.11) was used in immunohistochemistry to study its localization in Monckeberg's sclerosis and atherosclerosis. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology TNFSF10 products
includes other brands or spellings
|
| ih | | Santa Cruz Biotechnology antihuman TRAIL goat polyclonal antibody was used in immunohistochemistry to study its localization in Monckeberg's sclerosis and atherosclerosis. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-TRAIL antibody was used in western blot to investigate the role of human BVR in sodium arsenite (As) -mediated induction of HO-1 and in cytoprotection against apoptosis by small interference RNA-mediated gene silencing. |
BD BIOSCIENCES search BD Biosciences TNFSF10 products
includes other brands or spellings
|
| wb | | PharMingen TRAIL antibody was used in western blot to demonstrate multiple levels of molecular cross-talk between the TRAIL and interferon signaling pathways. |
DR. XIAODONG WANG
|
| wb | | Dr. Xiaodong Wang anti-Smac/DIABLO antibody was used in western blot to demonstrate that Smac/DIABLO can sensitize CL-1 tumor cells to Apo2L/TRAIL-mediated apoptosis. |
Articles Reviewed |
| 1. Chandan Kumar-Sinha et al. Molecular cross-talk between the TRAIL and interferon signaling pathways. 2002 |
| 2. Chuen-Pei Ng et al. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondr. 2002 |
| 3. Michael Schoppet et al. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. 2004 |
| 4. Tihomir Miralem et al. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. 2005 |
|